Clinical Trial Update: Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face [Phase 2]

View source ↗

Summary

A Phase 2 prospective study evaluating ingenol mebutate for non-invasive lentigo maligna of the face has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lentigo Maligna

Drugs mentioned

• Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Lentigo Maligna | Phase 2 | Status: COMPLETED